This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Incretins and the specific mechanism of action of liraglutide, the first applicable human glucagon-like peptide 1 analog in the treatment of type 2 diabetes, Journal of Receptor Ligand and Channel Research, September 2010, Taylor & Francis,
DOI: 10.2147/jrlcr.s6345.
You can read the full text:
The following have contributed to this page
